TPI-ASM8: Preliminary Phase II data

Preliminary data from a double-blind, placebo-controlled, Canadian Phase II trial in 17 patients showed that inhaled TPI-ASM8 was safe and well tolerated. TPI-ASM8 also reduced eosinophil counts. ...